<unk>  is used to treat primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.
Emapalumab
Olaratumab
Ustekinumab
Evolocumab
Anifrolumab
Dupilumab
Sarilumab
Burosumab